期刊文献+

CD133阳性/阴性肺癌细胞的分选、鉴定及差异基因的筛选 被引量:6

Isolation and Identification of CD133 Positive and Negative Cells from Human Lung Cancer and Screening of the Differential Genes between the Positive and Negative Cells
下载PDF
导出
摘要 背景与目的研究表明多种实体肿瘤中存在肿瘤干细胞(cancer stem cells,CSCs),肿瘤干细胞与非肿瘤干细胞的生物学特性存在已有的明显差异,而CD133被认为是肿瘤干细胞的标记物,因此CD133阳性细胞与CD133阴性细胞可能存在明显差异。本研究通过分选人肺腺癌A549细胞中的CD133阳性及CD133阴性细胞,鉴定两组细胞的生物学特性并在人组织标本进行验证,利用基因芯片筛选转移相关差异基因。方法采用磁式分选(magnetic activated cell sorting,MACS)的方法对人肺腺癌A549中CD133阳性细胞、CD133阴性细胞进行分选,通过无血清条件培养、平板克隆、血清诱导分化及基因芯片等实验,比较两组细胞"sphere"形成、细胞增殖、细胞分化以及差异基因,并在人组织标本进行CD133表达与临床特性的验证分析。结果 CD133阳性细胞能在无血清培养基中悬浮生长并形成"sphere";其平均克隆形成率(57.1%)明显高于CD133阴性细胞(3.3%);CD133阳性细胞能被血清诱导分化、表达腺癌标志物CK7;两组细胞中的19个转移基因表达水平相差两倍或以上,差异最高达12倍;肺癌组织中CD133阳性细胞主要分布于癌巢周边,数量稀少,其表达与肿瘤组织学分型、分级及临床分期无关。结论 CD133阳性肺腺癌A549细胞具有CSCs特性;两组细胞在转移相关基因的表达存在明显差异,其中CD82可能在CD133阳性细胞的转移机制中起重要作用。 Background and objective It has been proven that cancer stem cell existed in variety of cancer, which an significant difference of biological characteristics was observed between the cancer stem cells and non-cancer stem cells. And CD133 is considered to be cancer stem cell marker. So there may be significant differences in CD133- positive cells and CD133-negative cells. The aim of this study is to isolate CD133+ cells and CD133- cells from lung cancer cell line A549, explore their biological characteristics and screen the metastasis-related genes. Methods MACS was applied to isolate CD133+ cells and CD133- cells from human lung cancer cell line A549. To observe the formation of sphere, CD133+ cells and CD133-cells were cultured in serum-free DMEM-F12 medium(containing EGF, bF GF) in vitro. The colony formatting efficiency of CD133+ cells, CD133- cells and cells without sorting was tested by colony-forming assay. The differentiation of sphere was induced by culturing in DMEM-F12 medium(containing serum). The metastasis-related genes(84 genes) of CD133+ cells and CD133- cells were detected by using DNA microarray. Immunohistochemistry was used to detect the expression of CD133 protein in Human lung cancer tissue. Results CD133+ cells formed sphere in serum-free DMEM-F12 medium,while the CD133- cells failed to form sphere. The rates of CD133+ cell colony formation(57.1%) was significantly higher than that of CD133- cells(3.3%). Sphere(CD133+/CK7-) was induced to differentiate, and CK7 expression was found in differentiated cells. The expression levels of 19 metastasis-related genes from CD133+ cells and CD133- cells were significant different. Little CD133 positive cells which distributing around the cancer nests were found in lung cancer tissue. The expression of CD133 was not related to tumor types, cell differentiation or TNM stage. Conclusion CD133+ cells exhibit the characteristics of cancer stem cells. The difference of metastasis-related gene expression levels was
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2015年第3期123-130,共8页 Chinese Journal of Lung Cancer
基金 教育部博士点基金博导类课题(No.20134423110001) 广东省自然科学基金(No.S2012010010181) 广州市科技计划项目(No.2014Y2-00171) 广州市教育系统创新学术团队项目(No.13C06)资助~~
关键词 CD133 肺腺癌 磁式分选 基因芯片 转移相关基因 CD133 Adenocarcinoma of lung Magnetic activated cell sorting(MACS) DNA microarray Metastasis-related genes
  • 相关文献

参考文献3

二级参考文献24

  • 1Alba Rocco,Debora Compare,Gerardo Nardone.Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions[J].World Journal of Gastrointestinal Oncology,2012,4(3):54-59. 被引量:11
  • 2Zun-liang Xie Li-Min Jia Ye-Chun He Jiang-Tao Gao.Morphological observation of tumor infiltrating immunocytes in human rectal cancer[J].World Journal of Gastroenterology,2006,12(11):1757-1760. 被引量:3
  • 3Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors [J]. Cancer Res, 2003, 63(18) : 5821 - 5828. 被引量:1
  • 4Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters [J]. Cancer Res, 2006, 66(9) : 4553 -4557. 被引量:1
  • 5Galli R, Binda E, Orfanclli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma [ J ]. Cancer Res, 2004, 64( 19 ) : 7011 - 7021. 被引量:1
  • 6Ehrmann J, Kolar Z, Mokry J. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours [J]. J Clin Pathol, 2005, 58(2) : 222 -223. 被引量:1
  • 7Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche [ J l. Nat Rev Cancer, 2007, 7 (10) : 733 -736. 被引量:1
  • 8Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown [J]. J Cell Physiol, 2000, 182(3) : 311 -322. 被引量:1
  • 9Bouvier-Labit C, Chinot O, Ochi C, et al. Prognostic significance of Ki-67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas [ J]. Neuropathol Appl Neurobiol, 1998, 24(5) : 381 -388. 被引量:1
  • 10Quinones-Hinojosa A, Sanai N, Soriano-Navarro M, et al. Cellular composition and cytoarchitecture of the adult human subventricular zone : a niche of neural stem cells[J].J Comp Neurol, 2006, 494(3) : 415 - 434. 被引量:1

共引文献21

同被引文献108

  • 1张惠忠,魏益平,王梅,吴澄,杨艳旗,陈炬,曹永科.肿瘤干细胞标志物CD133和内皮素转化酶对非小细胞肺癌预后的影响[J].南方医科大学学报,2007,27(5):696-699. 被引量:11
  • 2Hilbe W, Dirnhofer S, Oberwasserlechner F, et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol. 2004; 57(9):965-969. 被引量:1
  • 3Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009; 106(38):16281 -16286. 被引量:1
  • 4Salnikov AV, Gladkich J, Moldenhauer G, et al. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small ceil lung cancer patients. Int J Cancer. 2010;126(4):950-958. 被引量:1
  • 5Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401. 被引量:1
  • 6Tirino V, Camerlingo R, Franco R, et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg. 2009; 36(3):446-453. 被引量:1
  • 7Liu D, Li WM, Mo XM, et ai. Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34 CD44 in lung cancer naive cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008;39(5):827-831. 被引量:1
  • 8Cui F, Wang J, Chen D, et al. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep. 2011;25(3):701-708. 被引量:1
  • 9Meng X, Li M, Wang X, et al. Both CD133+ and CD133- subpopulations ofA549 and H446 cells contain cancer-initiating cells. Cancer Sci. 2009; 100(6): 1040-1046. 被引量:1
  • 10Janikova M, Skarda J, Dziechciarkova M, et al. Identification of CD133+/nestin putative cancer stem cells in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky OIomouc Czech Repub. 2010154(4):321-326. 被引量:1

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部